TABLE 1.
Total No. pts (%) | 31 | (100) |
Age (yrs) | ||
Median | 63 | |
Range | 45–78 | |
No. gender (%) | ||
Male | 27 | (87) |
Female | 4 | (13) |
No. race (%) | ||
White | 30 | (97) |
Black | 0 | (0) |
Other | 1 | (3) |
No. clinical stage (%) | ||
I | 4 | (13) |
II | 7 | (23) |
III | 5 | (16) |
IV | 15 | (48) |
T1N0 | 4 | (13) |
T2N0 | 7 | (23) |
T3N0 | 4 | (13) |
T4aN0 | 1 | (3) |
T4bN0 | 7 | (23) |
N1M0 | 4 | (13) |
M1 | 4 | (13) |
Histologic variants (No.; %) | ||
None | 14 | (45) |
Signet ring cell | 11 | (35) |
Adenocarcinoma | 2 | (6) |
Micropapillary | 2 | (6) |
Other1 | 2 | (6) |
Includes one patient with foci of spindle cells, and one patient who had glandular and micropapillary features.